$164.84
+0.76%Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Chairman & Chief Executive Officer
Compensation
$9,547,623
Chief Applied Clinical Informatics Officer
Chief Managed Care Officer & Senior Vice President
EVice President, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary
Compensation
$2,780,954
Executive Vice President & Chief Financial Officer
Compensation
$2,987,881
Executive Vice President & Chief Information Officer
Compensation
$2,202,640
Executive Vice President & Chief Operating Officer
Compensation
$2,813,161
Executive Vice President of Commercial Operations
Compensation
$2,813,161
Executive Vice President of Corporate Development
Senior Vice President & Chief Compliance Officer
Vice President of Investor Relations
During the last 12 months, insiders have sold $12.65M worth of THC shares, with no buying activity reported.
0
0.00
16.2K
3.55M
-3.5M
-$3.55M
0
0.00
4.3K
920.92K
-921K
-$921K
0
0.00
23.5K
4.57M
-4.6M
-$4.57M
0
0.00
20.5K
3.62M
-3.6M
-$3.62M
No buying activity
Sutaria Saumya
Director, Officer: Ceo
$3.70M
Arbour Paola M
Officer: Evp, Chief Information Officer
$2.89M
Foo Lisa Y
Officer: Evp, Chief Operating Officer
$1.44M
Arnst Thomas W
Officer: Evp, Chief Admin. Officer & Gc
$1.12M
West Nadja
Director
$962K
Strong bearish signal with $12.65M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
THC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 16, 2026 | May 27, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 11, 2025 | May 22, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 12, 2024 | May 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 14, 2023 | April 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 25, 2022 | May 06, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 26, 2021 | May 06, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 17, 2020 | May 28, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 22, 2019 | May 02, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 30, 2018 | May 03, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 24, 2017 | May 04, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.